NCT03067935 2018-05-21
Individual Patient Expanded Access-Glembatumumab Vedotin
Celldex Therapeutics
No longer available
Clinical Trials
1 trialsNo longer available × Metastatic gpNMB Expressing Triple Negative Breast Cancer × glembatumumab vedotin × Clear all